These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1236 related articles for article (PubMed ID: 7245026)

  • 1. Regional lymph node dissection for malignant melanoma of the extremities.
    Roses DF; Harris MN; Gumport SL; Michelassi F; Coffey JA; Dubin N
    Surgery; 1981 Jun; 89(6):654-9. PubMed ID: 7245026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma.
    Badgwell B; Xing Y; Gershenwald JE; Lee JE; Mansfield PF; Ross MI; Cormier JN
    Ann Surg Oncol; 2007 Oct; 14(10):2867-75. PubMed ID: 17671814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional lymph node dissections in malignant melanoma.
    Lawton GP; Ariyan S
    Clin Plast Surg; 2000 Jul; 27(3):431-40, ix. PubMed ID: 10941563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998.
    Fisher SR
    Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
    Nowecki ZI; Rutkowski P; Michej W
    Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumor biology of melanoma nodal metastases.
    Miliotes G; Albertini J; Berman C; Heller R; Messina J; Glass F; Cruse W; Rapaport D; Puleo C; Fenske N; Petsoglou C; Deconti R; Lyman G; Reintgen D
    Am Surg; 1996 Jan; 62(1):81-8. PubMed ID: 8540654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective use of wide excision with elective lymph node dissection for malignant melanoma.
    Fortner JG; Rosen PP; Maclean BJ
    Pathol Annu; 1985; 20 Pt 1():239-46. PubMed ID: 3991238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
    Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
    Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of patients with pathologic stage II cutaneous malignant melanoma.
    Roses DF; Provet JA; Harris MN; Gumport SL; Dubin N
    Ann Surg; 1985 Jan; 201(1):103-7. PubMed ID: 3966826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma.
    Hughes TM; A'Hern RP; Thomas JM
    Br J Surg; 2000 Jul; 87(7):892-901. PubMed ID: 10931025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ilioinguinal lymph node dissection for palpable metastatic melanoma to the groin.
    Allan CP; Hayes AJ; Thomas JM
    ANZ J Surg; 2008 Nov; 78(11):982-6. PubMed ID: 18959697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognosis after sentinel node biopsy in malignant melanoma].
    Lock-Andersen J; Horn J; Sjøstrand H
    Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversies in the management of metastatic melanoma to regional lymphatic basins.
    Mack LA; McKinnon JG
    J Surg Oncol; 2004 Jul; 86(4):189-99. PubMed ID: 15221926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs.
    Veronesi U; Adamus J; Bandiera DC; Brennhovd IO; Caceres E; Cascinelli N; Claudio F; Ikonopisov RL; Javorskj VV; Kirov S; Kulakowski A; Lacoub J; Lejeune F; Mechl Z; Morabito A; Rodé I; Sergeev S; van Slooten E; Szcygiel K; Trapeznikov NN
    N Engl J Med; 1977 Sep; 297(12):627-30. PubMed ID: 895764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
    Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
    Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognosis of malignant melanoma following dissection regional lymph node metastases].
    Sprakel B; Stenschke F; Unnewehr M; Ladas A; Senninger N
    Chirurg; 2003 Jan; 74(1):55-60. PubMed ID: 12552406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preventive lymph node excision in the treatment concept of melanoma of the extremities].
    Binder J; Henneking K
    Zentralbl Chir; 1996; 121(6):474-7. PubMed ID: 8767334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sentinel node biopsy in cutaneous malignant melanoma of the lower extremities].
    Kjaer BK; Knudsen MA; Dahlstrøm KK
    Ugeskr Laeger; 1999 Apr; 161(16):2358-61. PubMed ID: 10235040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical technique and postoperative morbidity following radical inguinal/iliacal lymph node dissection--a prospective study in 67 patients with malignant melanoma metastatic to the groin].
    Mall JW; Reetz C; Koplin G; Schäfer-Hesterberg G; Voit C; Neuss H
    Zentralbl Chir; 2009 Sep; 134(5):437-42. PubMed ID: 19757344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elective and therapeutic regional lymph node dissection for cutaneous malignant melanoma: experience of the British Columbia Cancer Agency, 1972 to 1981.
    Carmichael VE; Robins RE; Wilson KS
    Can J Surg; 1992 Dec; 35(6):600-4. PubMed ID: 1458385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.